CHAT Protein

Overview

Choline acetyltransferase (CHAT) is the enzyme that synthesizes the neurotransmitter acetylcholine (ACh) from choline and acetyl-CoA^{1Choline acetyltransferase and acetylcholine2011 · Journal of Neurochemistry · PMID 21495839Open reference}. It is the definitive marker for cholinergic neurons—cells that use acetylcholine as their primary neurotransmitter. CHAT is essential for cholinergic signaling throughout the nervous system, including in brain regions critical for memory and attention (basal forebrain), motor control (brainstem and spinal cord), and autonomic function.

The cholinergic system is prominently affected in Alzheimer’s disease, where CHAT activity is dramatically reduced in the basal forebrain and cortex. This loss underlies the cognitive deficits characteristic of AD and has driven the development of cholinesterase inhibitor drugs (donepezil, rivastigmine, galantamine) as symptomatic treatments^{2Cholinergic neurons in AD and cholinergic therapies2023 · Nature Reviews Neurology · PMID 37452156Open reference}.

Structure and Function

Protein Structure

CHAT has a characteristic enzyme architecture^{1Choline acetyltransferase and acetylcholine2011 · Journal of Neurochemistry · PMID 21495839Open reference}:

1. N-terminal region: Contains subcellular targeting signals

2. Catalytic core: ~400 amino acids forming the active site

3. C-terminal domain: Regulatory elements and dimerization interface

The enzyme is organized as a homodimer, with each subunit containing distinct substrate-binding sites for choline and acetyl-CoA.

Catalytic Mechanism

CHAT catalyzes a simple transfer reaction:

Choline + Acetyl-CoA → Acetylcholine + CoA

The reaction proceeds through a ternary complex mechanism:

1. Choline binds to CHAT

2. Acetyl-CoA binds

3. Acetyl group transfers to choline

4. Acetylcholine and CoA are released

Regulation

CHAT activity is regulated at multiple levels:

Regulatory Mechanism	Effect
Transcriptional control	Cell-type specific expression
Alternative splicing	Multiple isoforms with different properties
Post-translational modification	Phosphorylation affects activity
Product inhibition	Acetylcholine feedback

Normal Biological Function

Acetylcholine Synthesis

CHAT is the sole enzyme for ACh biosynthesis:

1. Substrate uptake: Choline is imported via high-affinity transporters

2. Acetyl-CoA source: Mitochondrial metabolism supplies acetyl groups

3. Vesicular packaging: Synthesized ACh is packaged into vesicles by VAChT

Cholinergic Neurons

CHAT defines the cholinergic system:

1. Basal forebrain: Projections to cortex and hippocampus (memory/attention)

2. Brainstem: Pedunculopontine/laterodorsal nuclei (arousal, REM sleep)

3. Spinal cord: Motor neurons and interneurons (motor control)

4. Peripheral: Autonomic preganglionic neurons, neuromuscular junction

Regional Specialization

Different CHAT isoforms are expressed in:

• Brain: Neuronal isoforms with high catalytic efficiency

• Muscle: Alternative splicing generates tissue-specific forms

Role in Neurodegeneration

Alzheimer’s Disease

CHAT loss is a hallmark of AD pathophysiology^{2Cholinergic neurons in AD and cholinergic therapies2023 · Nature Reviews Neurology · PMID 37452156Open reference}:

Cholinergic Degeneration:

• Basal forebrain cholinergic neurons degenerate early

• CHAT activity reduced by 60-90% in AD cortex

• Loss correlates with cognitive deficits

Pathogenic Mechanisms:

• Amyloid pathology directly damages cholinergic neurons

• Tau pathology in basal forebrain

• Neuroinflammation contributes to neuron loss

Diagnostic Significance:

• CHAT activity in CSF may reflect cholinergic integrity

• PET ligands for cholinergic terminals in development

Parkinson’s Disease

CHAT alterations in PD include:

1. Cortical cholinergic dysfunction: Related to cognitive impairment

2. Non-motor symptoms: Cholinergic deficits contribute to dementia

3. Treatment overlap: Cholinesterase inhibitors used for PD dementia

Other Conditions

Disorder	CHAT Involvement
DLB	Severe cholinergic loss
MCI	Early cholinergic changes
Myasthenia gravis	Autoantibodies affect function
ALS	Motor neuron cholinergic changes

Therapeutic Implications

Current Treatments

Cholinesterase inhibitors are standard AD therapy^{3Cholinergic system: emerging targets for AD therapy2018 · Drug Discovery Today · PMID 29626556Open reference}:

Drug	Mechanism	Status
Donepezil	AChE inhibition	Approved
Rivastigmine	AChE/BChE inhibition	Approved
Galantamine	AChE modulation	Approved

These drugs increase synaptic acetylcholine by inhibiting its breakdown, partially compensating for CHAT loss.

Emerging Strategies

Strategy	Approach	Status
CHAT gene therapy	Restore CHAT expression	Preclinical
Acetylcholine receptor agonists	Direct receptor activation	Various
Neurotrophic factors	Support cholinergic neurons	Research

Biomarker Potential

CHAT-related biomarkers:

• CSF CHAT activity: May reflect cholinergic neuron health

• Imaging: Cholinergic terminal density markers

Key Publications

1. Misawa H, et al. (2011) Choline acetyltransferase. Journal of Neurochemistry

2. O’Brien M, et al. (2023) Cholinergic neurons in AD. Nature Reviews Neurology

3. Hampel H, et al. (2018) Cholinergic system in AD therapy. Drug Discovery Today

Cross-References

• CHAT Gene — Gene encoding CHAT

• Acetylcholine — The neurotransmitter

• Alzheimer’s Disease — Primary disease

• Parkinson’s Disease — Related disease

• Cholinergic System — Neural system

See Also

• Basal Forebrain

• Acetylcholinesterase

• Cholinesterase Inhibitors